← Evidence map

TrialBlood2012

Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.

Yvette L Kasamon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it

The trial

NCT00369681phase 251 enrolled2006
Full record →Abstract, authors, funding and every citing paper · PMID 22343727